Published in Acta Neuropathol on January 01, 1992
Immunocytochemical and ultrastructural studies of the motor cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1994) 0.82
The size distribution of neurons in the motor cortex in amyotrophic lateral sclerosis. J Anat (2005) 0.80
The neuropathological signature of bulbar-onset ALS: A systematic review. Neurosci Biobehav Rev (2017) 0.77
Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis. Front Aging Neurosci (2016) 0.75
The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem (1966) 46.81
The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry (1970) 4.50
Aberrant neurofilament phosphorylation in Alzheimer disease. Proc Natl Acad Sci U S A (1985) 2.96
Synaptic morphology in the normal and degenerating nervous system. Int Rev Cytol (1966) 2.84
Amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry (1953) 2.62
Proximal axonal enlargement in motor neuron disease. Neurology (1968) 2.48
Ubiquitin-mediated pathways for intracellular proteolysis. Annu Rev Cell Biol (1987) 2.32
Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc Natl Acad Sci U S A (1987) 1.98
Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol (1991) 1.67
New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett (1991) 1.60
Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol (1988) 1.49
Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J Neuropathol Exp Neurol (1986) 1.48
Phosphorylation of neurofilaments is altered in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1988) 1.40
Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis. Ann Neurol (1990) 1.40
Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann Neurol (1986) 1.35
[Neuropathological study of 61 cases of amyotrophic lateral sclerosis. Nosological discussion]. Rev Neurol (Paris) (1972) 1.28
The association of actin with Hirano bodies. J Neuropathol Exp Neurol (1983) 1.20
Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells. Acta Neuropathol (1990) 1.19
Fine structure of anterior horns in patients without amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1985) 1.11
Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study. Brain (1989) 1.10
Focal accumulation of phosphorylated neurofilaments within anterior horn cell in familial amyotrophic lateral sclerosis. Acta Neuropathol (1989) 1.10
Filaments of Pick's bodies contain altered cytoskeletal elements. Am J Pathol (1987) 1.03
Origin of the pericellular baskets of the pyramidal cells of the human motor cortex: a Golgi study. Brain Res (1969) 0.99
A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis. Acta Neuropathol (1987) 0.96
A unique pattern of astrocytosis in the primary motor area in amyotrophic lateral sclerosis. Acta Neuropathol (1991) 0.93
Ubiquitin in motor neuron disease: study at the light and electron microscope. J Neuropathol Exp Neurol (1991) 0.92
Inclusion bodies in motor cortex and brainstem of patients with motor neurone disease are detected by immunocytochemical localisation of ubiquitin. Neurosci Lett (1989) 0.84
Cytoskeletal pathology in motor neuron diseases. Adv Neurol (1991) 0.83
Expression of neurofilament proteins by Purkinje cells: ultrastructural immunolocalization with monoclonal antibodies. Brain Res (1988) 0.83
The reinterpretation of the immunochemical study of Alzheimer neurofibrillary tangles. Ann Med (1989) 0.79
Presynaptic organelles and junctional integrity. J Cell Biol (1971) 0.78
Molecular misreading: a new type of transcript mutation expressed during aging. Neurobiol Aging (2001) 3.06
A sex difference in the human brain and its relation to transsexuality. Nature (1995) 2.64
The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev (2007) 1.94
The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res (1985) 1.87
Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol Psychiatry (2008) 1.78
Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in Alzheimer patients by application of nonparametric methods. Chronobiol Int (1999) 1.77
Oxytocin deficiency at delivery with epidural analgesia. Br J Obstet Gynaecol (1983) 1.77
Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry (1990) 1.74
Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry (1997) 1.71
Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab (2000) 1.60
Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology (1994) 1.60
Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry (1996) 1.54
The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol (2000) 1.53
The vasopressinergic innervation of the brain in normal and castrated rats. J Comp Neurol (1985) 1.45
Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol (1975) 1.43
[Transdermal opioid administration: the pain plaster]. Ned Tijdschr Geneeskd (1997) 1.39
[Towards an accreditation system for the Dutch hospitals]. Ned Tijdschr Geneeskd (1999) 1.38
Muscular changes in the guinea pig caused by chronic ascorbic acid deficiency. J Neurol Sci (1991) 1.37
Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry (1995) 1.29
Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res (1978) 1.29
A sexually dimorphic nucleus in the human brain. Science (1985) 1.27
Brain banking and the human hypothalamus--factors to match for, pitfalls and potentials. Prog Brain Res (1992) 1.26
Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry (1996) 1.22
Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci (2001) 1.22
The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain. Neurogenetics (1998) 1.21
Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol (2001) 1.19
Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys (2000) 1.18
VIP neurons in the human SCN in relation to sex, age, and Alzheimer's disease. Neurobiol Aging (1996) 1.18
Apoptosis during sexual differentiation of the bed nucleus of the stria terminalis in the rat brain. J Neurobiol (2000) 1.17
Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol (1990) 1.16
A new actigraph for long-term registration of the duration and intensity of tremor and movement. IEEE Trans Biomed Eng (1998) 1.15
Physical activity and executive functions in the elderly with mild cognitive impairment. Aging Ment Health (2005) 1.13
Senescence, sleep, and circadian rhythms. Ageing Res Rev (2002) 1.13
Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophypopseal system. J Neural Transm (1975) 1.11
Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging (1990) 1.10
Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin. Brain (2007) 1.09
Ontogeny of the vasopressinergic neurons of the suprachiasmatic nucleus and their extrahypothalamic projections in the rat brain--presence of a sex difference in the lateral septum. Brain Res (1981) 1.07
Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol (2000) 1.07
Alterations in circadian rhythmicity of the vasopressin-producing neurons of the human suprachiasmatic nucleus (SCN) with aging. Brain Res (1994) 1.07
Can specificity ever be proved in immunocytochemical staining. J Histochem Cytochem (1977) 1.07
Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain (1995) 1.05
Progression of paclitaxel-induced neuropathy following discontinuation of treatment. Muscle Nerve (1997) 1.05
Immuno-electron microscopical demonstration of vasopressin and oxytocin synapses in the limbic system of the rat. Cell Tissue Res (1979) 1.05
Phosphatidylethanolamine mediates insertion of the catalytic domain of leader peptidase in membranes. FEBS Lett (1998) 1.04
Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J Neuropathol Exp Neurol (2000) 1.04
Negative sural nerve biopsy in neurolymphomatosis. J Neurol (1999) 1.03
Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab (1997) 1.03
Long-term fitness training improves the circadian rest-activity rhythm in healthy elderly males. J Biol Rhythms (1997) 1.03
Vasopressin and the output of the hypothalamic biological clock. J Neuroendocrinol (2010) 1.02
Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab (1999) 1.02
Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis. Arch Neurol (1995) 1.00
The sexually dimorphic nucleus of the preoptic area in the human brain: a comparative morphometric study. J Anat (1989) 1.00
Non-pharmacological treatment of sleep and wake disturbances in aging and Alzheimer's disease: chronobiological perspectives. Behav Brain Res (1993) 0.99
A solitary spinal cord toxoplasma lesion after peripheral stem-cell transplantation. J Neurol (2001) 0.99
Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer. J Clin Oncol (2001) 0.99
Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications. Rev Neurosci (2007) 0.99
Massive haemoptysis after radiotherapy in inoperable non-small cell lung carcinoma: is endobronchial brachytherapy really a risk factor? Radiother Oncol (1998) 0.98
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol (2013) 0.98
DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology. J Neuropathol Exp Neurol (1997) 0.97
T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clin Otolaryngol Allied Sci (1992) 0.97
Microwave-enhanced in situ end-labeling of fragmented DNA: parametric studies in relation to postmortem delay and fixation of rat and human brain. J Histochem Cytochem (1995) 0.96
Intra-CSF administered recombinant adenovirus causes an immune response-mediated toxicity. Gene Ther (2000) 0.96
Synchronous and metachronous tumours in patients with head and neck cancer. J Laryngol Otol (1983) 0.96
Ataxia and nystagmus induced by injection of local anesthetics in the Neck. Ann Neurol (1977) 0.96
A direct androgenic involvement in the expression of human corticotropin-releasing hormone. Mol Psychiatry (2006) 0.95
Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol (2001) 0.95
Changes in vasopressin cells of the rat suprachiasmatic nucleus with aging. Brain Res (1987) 0.95
Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons. J Clin Endocrinol Metab (1998) 0.94
Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: indications for a processing defect. J Clin Endocrinol Metab (1998) 0.94
A prospective longitudinal study on radiation-induced hearing loss. Am J Surg (1994) 0.94
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease. Ann Neurol (1999) 0.94
Animal models of amyotrophic lateral sclerosis and the spinal muscular atrophies. J Neurol Sci (1989) 0.93
Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience (1996) 0.93
Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. Neuroscience (2011) 0.92
Vasopressin and oxytocin: distribution and putative functions in the brain. Prog Brain Res (1983) 0.91
Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis. J Neurol (1993) 0.91
Gene expression of GABA and glutamate pathway markers in the prefrontal cortex of non-suicidal elderly depressed patients. J Affect Disord (2012) 0.91
Sexual dimorphism of the human brain: myth and reality. Exp Clin Endocrinol (1991) 0.91
Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4. Alzheimer Dis Assoc Disord (1998) 0.91
The Netherlands brain bank--a clinico-pathological link in aging and dementia research. J Neural Transm Suppl (1993) 0.90
Increased expression of estrogen receptor alpha and beta in the nucleus basalis of Meynert in Alzheimer's disease. Neurobiol Aging (2001) 0.90
Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease. Alzheimer Dis Assoc Disord (1998) 0.90
Walking the line: a randomised trial on the effects of a short term walking programme on cognition in dementia. J Neurol Neurosurg Psychiatry (2009) 0.90
The presence of biologically labile compounds during ischemia and their relationship to the EEG in rat cerebral cortex and hypothalamus. J Neurochem (1972) 0.89
Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer. Laryngoscope (1999) 0.89
Leptomeningeal metastasis after surgical resection of brain metastases. J Neurol Neurosurg Psychiatry (1999) 0.88
Long-term effects of cranial irradiation for childhood malignancy on sleep in adulthood. Eur J Endocrinol (2004) 0.88
Gravitational artefact in frequency spectra of movement acceleration: implications for actigraphy in young and elderly subjects. J Neurosci Methods (1996) 0.88
Extrahypothalamic vasopressin and oxytocin in the human brain; presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Res (1986) 0.88
Decreased hippocampal metabolic activity in Alzheimer patients is not reflected in the immunoreactivity of cytochrome oxidase subunits. Exp Neurol (2000) 0.88
Circadian rhythms and the suprachiasmatic nucleus in perinatal development, aging and Alzheimer's disease. Prog Brain Res (1992) 0.88
Morphometric analysis of the suprachiasmatic and paraventricular nuclei in the human brain: sex differences and age-dependent changes. J Anat (1988) 0.88
Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res (1990) 0.88
P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease. Exp Neurol (2000) 0.88
Alzheimer's disease and NGF signaling. J Neural Transm (Vienna) (2004) 0.88
Vasoactive intestinal polypeptide neuron changes in the senile rat suprachiasmatic nucleus. Neurobiol Aging (1988) 0.88
Testosterone fails to reverse spatial memory decline in aged rats and impairs retention in young and middle-aged animals. Behav Neural Biol (1990) 0.88
Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res (1993) 0.87
Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry (2001) 0.87